173 related articles for article (PubMed ID: 36078325)
1. Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide.
Botti G; Bianchi A; Pavan B; Tedeschi P; Albanese V; Ferraro L; Spizzo F; Del Bianco L; Dalpiaz A
Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078325
[TBL] [Abstract][Full Text] [Related]
2. Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles.
Botti G; Bianchi A; Dalpiaz A; Tedeschi P; Albanese V; Sorrenti M; Catenacci L; Bonferoni MC; Beggiato S; Pavan B
Expert Opin Drug Deliv; 2023; 20(11):1657-1679. PubMed ID: 38014509
[TBL] [Abstract][Full Text] [Related]
3. Characterization and Hydrolysis Studies of a Prodrug Obtained as Ester Conjugate of Geraniol and Ferulic Acid by Enzymatic Way.
Lerin LA; Botti G; Dalpiaz A; Bianchi A; Ferraro L; Chaibi C; Zappaterra F; Meola D; Giovannini PP; Pavan B
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892454
[TBL] [Abstract][Full Text] [Related]
4. Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.
Dalpiaz A; Ferraro L; Perrone D; Leo E; Iannuccelli V; Pavan B; Paganetto G; Beggiato S; Scalia S
Mol Pharm; 2014 May; 11(5):1550-61. PubMed ID: 24717116
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid microparticles for the stability enhancement of a dopamine prodrug.
Dalpiaz A; Cacciari B; Mezzena M; Strada M; Scalia S
J Pharm Sci; 2010 Nov; 99(11):4730-7. PubMed ID: 20845469
[TBL] [Abstract][Full Text] [Related]
6. Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.
Yadav VR; Suresh S; Devi K; Yadav S
J Pharm Pharmacol; 2009 Mar; 61(3):311-21. PubMed ID: 19222903
[TBL] [Abstract][Full Text] [Related]
7. Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles.
Scalia S; Mezzena M
Drug Dev Ind Pharm; 2009 Feb; 35(2):192-8. PubMed ID: 18785040
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid microparticles for the stability enhancement of the polar drug N6-cyclopentyladenosine.
Dalpiaz A; Mezzena M; Scatturin A; Scalia S
Int J Pharm; 2008 May; 355(1-2):81-6. PubMed ID: 18178347
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid micro-dispersions (SLMs) based on PEGylated solidified reverse micellar solutions (SRMS): a novel carrier system for gentamicin.
Kenechukwu FC; Momoh MA; Nnamani PO; Attama AA
Drug Deliv; 2015; 22(6):710-22. PubMed ID: 24724962
[TBL] [Abstract][Full Text] [Related]
10. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the radical-scavenging activity of the phenolcarboxylic acids caffeic acid, p-coumaric acid, chlorogenic acid and ferulic acid, with or without 2-mercaptoethanol, a thiol, using the induction period method.
Kadoma Y; Fujisawa S
Molecules; 2008 Oct; 13(10):2488-99. PubMed ID: 18923340
[TBL] [Abstract][Full Text] [Related]
12. The Structure-Antioxidant Activity Relationship of Ferulates.
Karamać M; Koleva L; Kancheva VD; Amarowicz R
Molecules; 2017 Mar; 22(4):. PubMed ID: 28346342
[TBL] [Abstract][Full Text] [Related]
13. Formulation, in vitro and in vivo evaluation of halofantrine-loaded solid lipid microparticles.
Ogbonna JDN; Kenechukwu FC; Nwobi CS; Chibueze OS; Attama AA
Pharm Dev Technol; 2015 Dec; 20(8):941-948. PubMed ID: 25133606
[TBL] [Abstract][Full Text] [Related]
14. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the release behavior of solid lipid microparticles in different simulated gastrointestinal fluids.
Albertini B; Bertoni S; Perissutti B; Passerini N
Colloids Surf B Biointerfaces; 2019 Jan; 173():276-285. PubMed ID: 30300834
[TBL] [Abstract][Full Text] [Related]
16. Development and formulation of antidiabetic property of
Eze KC; Ugwu CE; Odo FS; Njoku GC
J Microencapsul; 2022; 39(7-8):626-637. PubMed ID: 36398605
[No Abstract] [Full Text] [Related]
17. Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells.
Senthil Kumar C; Thangam R; Mary SA; Kannan PR; Arun G; Madhan B
Carbohydr Polym; 2020 Mar; 231():115682. PubMed ID: 31888816
[TBL] [Abstract][Full Text] [Related]
18. Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo.
Umeyor EC; Kenechukwu FC; Ogbonna JD; Chime SA; Attama A
J Microencapsul; 2012; 29(3):296-307. PubMed ID: 22283701
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
Momoh MA; Kenechukwu FC; Attama AA
Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study.
Martignoni I; Trotta V; Lee WH; Loo CY; Pozzoli M; Young PM; Scalia S; Traini D
J Microencapsul; 2016 Dec; 33(8):735-742. PubMed ID: 27841060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
